Codes / ICD10CM / M1A.271

M1A.271 Drug-induced chronic gout, right ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Right Ankle and Foot

Summary

Drug-induced chronic gout, right ankle and foot is a form of arthritis affecting the right ankle and foot joints, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right ankle and foot joints and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense pain in the right ankle or foot, often with swelling and redness
  • Persistent warmth and tenderness in the affected joints
  • Formation of tophi (hard, painless lumps) around the right ankle or foot
  • Stiffness and limited range of motion in the right ankle or foot
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis may identify urate crystals. Imaging studies like X-rays or ultrasound can assess joint damage or tophi formation. The right ankle and foot are specifically evaluated to confirm localization.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) or anti-inflammatory drugs for flare-ups. Lifestyle modifications, such as dietary changes, may be recommended. In severe cases, tophi removal or joint surgery may be necessary.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels and adjust treatment. Untreated or poorly managed cases may lead to progressive joint damage or disability.

Complications

  • Chronic joint damage or deformity in the right ankle or foot
  • Persistent pain and reduced mobility
  • Development of tophi, which may ulcerate or become infected
  • Increased risk of kidney stones or renal impairment

Lifestyle & Prevention

  • Avoid medications known to raise uric acid levels when possible
  • Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
  • Stay hydrated to support uric acid excretion
  • Manage weight and exercise regularly to reduce joint stress

When to Seek Professional Help

Seek medical attention if you experience sudden, severe pain in the right ankle or foot, persistent swelling, or signs of infection (e.g., fever, redness). Early intervention can prevent complications and improve outcomes.

Tips for Medical Coders

Document the specific site (right ankle and foot) and confirm the drug-induced etiology. Ensure clinical notes specify the affected joints and any contributing medications. Code M1A.271 is used when the condition is localized to the right ankle and foot and is drug-induced.

Book a walkthrough

M1A.271 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.